Quantifying Expression of Interneuron Subtype Markers for Dlx-2 Transfected NG2 Cells by Nolan, Timothy
University of Connecticut 
OpenCommons@UConn 
Honors Scholar Theses Honors Scholar Program 
Spring 5-1-2019 
Quantifying Expression of Interneuron Subtype Markers for Dlx-2 
Transfected NG2 Cells 
Timothy Nolan 
timothy.nolan@uconn.edu 
Follow this and additional works at: https://opencommons.uconn.edu/srhonors_theses 
 Part of the Molecular and Cellular Neuroscience Commons, Molecular Genetics Commons, Nervous 
System Commons, Nervous System Diseases Commons, Neurology Commons, and the Neurosciences 
Commons 
Recommended Citation 
Nolan, Timothy, "Quantifying Expression of Interneuron Subtype Markers for Dlx-2 Transfected NG2 Cells" 
(2019). Honors Scholar Theses. 647. 
https://opencommons.uconn.edu/srhonors_theses/647 
Quantifying Expression of 
Interneuron Subtype Markers for 
Dlx-2 Transfected NG2 Cells 
 
 
 
 
Timothy Nolan 
Undergraduate Honors Thesis 
May 2019 
 
 
Akiko Nishiyama Laboratory 
Department of Physiology and Neurobiology 
University of Connecticut 
 
  
Table of Contents 
 
Abstract 3 
Introduction 4 
Materials and Methods 8 
Results 12 
Discussion 20 
Conclusion 22 
Acknowledgements 22 
References 23 
 
  
Abstract 
 
Neurons are a post-mitotic cell population, and therefore, they are not able to regenerate in vivo 
after a traumatic injury. Because inhibitory GABAergic interneurons and oligodendrocyte 
precursor cells (OPCs) are derived from the same precursor, recent studies have focused on 
transforming these OPCs into GABAergic neurons. However, there are different types of 
GABAergic interneurons that have different electrophysiological responses, which can lead to 
functional differences. The Nishiyama laboratory had already used a key gene in GABAergic 
interneuron and OPC differentiation, Distal-less homeobox 2 (Dlx-2), to transfect OPCs; early 
electrophysiology tests showed most of these transfected cells behaved like immature neurons, 
but some behaved how fast-spiking parvalbumin-containing GABAergic neurons would. To 
further clarify what type of GABAergic interneurons our Dlx-2 transfected cells are becoming, I 
chose fourteen genes to quantify and compare, utilizing reverse-transcriptase polymerase chain 
reactions (qRT-PCR). After designing and optimizing primer pairs to target these genes, five 
replicates of transfected cells were tested; results were analyzed using both the 2−ΔΔCT method 
and by evaluating raw cycle thresholds for each gene. Gad67, the gene responsible for 
producing GABA, was significantly more expressed in the Dlx-2-transfected samples, showing 
that these cells are differentiating into GABAergic interneurons. Although a few genes linked to 
the parvalbumin- and somatostatin-containing types of GABAergic interneurons were 
significantly more expressed in the Dlx-2-transfected samples, most genes were not significantly 
changed, suggesting that these cells are either expressing a mixed phenotype or are not 
developed enough at this time point to clearly show a subtype.  
 
 
  
Introduction 
 
The natural response of the adult cortical tissue to injury is not neurogenesis to replace the 
damaged neurons, but rather a glial response of migrating to the site of injury and inhibiting 
neurogenesis and further immune cell responses 1,2,3. As a part of this response, certain central 
nervous system cell populations that are still mitotically active proliferate to enhance their 
response. Oligodendrocyte precursor cells (OPCs) are considered a fourth major glial cell type, 
making up 2-8% of glial cells in the brain; since these are ubiquitous, these are able to divide 
and differentiate into oligodendrocytes all throughout the brain 4. OPCs are often characterized 
by their expression of the transmembrane proteoglycan NG2 5,6 and the alpha receptor of 
platelet-derived growth factor (PDGFRa) 7. NG2 is a neurexin, helping to strengthen synapses 
with nearby axons 8 and direct cell migration in development 9. 
 
OPCs share the same progenitor cells with GABAergic interneurons, which are neurons that 
synapse onto other neurons and express the inhibitory neurotransmitter Gamma-aminobutyric 
acid (GABA), and the regulation of a few specific genes regulates which fate the progenitor cell 
will follow. These neural progenitor cells, or NPCs, originate in the ganglionic eminences 10 and 
start expressing the basic helix-loop-helix transcription factor Olig2 at E8.5 11; the subpopulation 
that express PDGFRa, starting at E13.5, are fully committed to becoming OPCs once they start 
expressing NG2, first seen at E15 12,13. NG2 is only expressed after the high-mobility-group 
transcription factors Sox9 and Sox10 are expressed alongside Olig2; both Sox10 and Olig2 bind 
to an enhancer for NG2, increasing its expression 14. 
 
The Dlx homeodomain transcription factor family is a key regulator in NPC development during 
embryogenesis. By E12, NPCs in the lateral and medial ganglionic eminences are significantly 
expressing both Dlx-1 and Dlx-2, which will then stimulate expression of related transcription 
factors Dlx-5 and Dlx-6 15. Furthermore, the expression of transcription factors Dlx-1 and Dlx-2 
has a negative correlation with the expression of the basic helix-loop-helix Ascl1 (formerly called 
Mash1), which actually has a binding site on the intergenic region between Dlx-1 and Dlx-2. 
Knocking out Ascl1 leads to increases in Dlx-1 and Dlx-2 expression and a decrease in OPC 
production from NPCs, whereas knocking out Dlx-1 and Dlx-2 leads to increased Ascl1 
expression and OPC formation 16. These findings suggest that Dlx-1 and Dlx-2 are directly 
related to the regulation of NPC differentiation and fate determination. In addition, when the Dlx-
2 is knocked out, GABAergic interneuron differentiation can be impaired both in vivo and in vitro 
17; these mutations have also been shown to decrease the expression of Dlx5 and Dlx618. 
Knocking out either the Dlx-1 or Dlx-2 gene also can impair neuronal migration in the striatum 19, 
and improper development of these GABAergic interneurons has been proposed to cause an 
imbalance leading to over-excitation in the cortex, and is potentially linked to Autism 20 . 
Because of its role in regulating NPC’s differentiation into either GABAergic interneurons or 
OPCs, and the major neurodevelopmental defects associated when this gene is knocked out, 
Dlx-2 is an ideal gene to clone to induce oligodendrocyte precursor cells to follow a GABAergic 
interneuron fate. 
 
These NG2 cells are known to differentiate into oligodendrocytes, but they are primarily 
committed to the oligodendrocyte lineage by the time of birth in vivo. In vitro, the potential for 
NG2 cells to de-differentiate into a multipotential neural stem cell has been shown under rare 
circumstance when they are cultured with appropriate mixes of extracellular signals or 
transcription factors 21. Some cell culture studies showing isolated OPCs can become 
oligodendrocyte-type-2 astrocyte (O2A) progenitor cells, which could then differentiate into 
either astrocytes or oligodendrocytes; there are no identified in vivo analogs to these O2A 
progenitor cells, suggesting this finding may just be an artifact 7. In vivo studies involving central 
nervous system lesions show these NG2 cells accumulate near the lesion, can contribute to the 
glial scarring, and can potentially differentiate into astrocytes or oligodendrocytes 22, although 
results are mixed regarding NG2 cells’ truly differentiate into astrocytes in vivo 23,24,25. 
Additionally, NG2 cell fate mapping rarely labels astrocytes 26,27.   
 
Alongside their ability to respond to injury, NG2 cells also contact neurons under normal 
conditions and can respond to neurotransmitters. NG2 cells are typically in close proximity of 
neurons’ nodes of Ranvier and synapses on the neuron’s somas 28. Furthermore, these cells 
can receive input from their synapses with both glutamatergic 29 and GABAergic neurons 30. 
NG2 cells can also respond to changes in their membrane potential through their voltage-gated 
sodium channels 31 and ionotropic glutamate receptors 32.  
 
Attempts to divide neurons into different classes grow more complex as more techniques and 
characteristics are made available. Initially, Ramón and Cajal classified different neural cells 
based on their size and morphology, introducing the ideas as projection and interneurons 33. 
Since then, it has become possible to identify the neurotransmitters (e.g. GABA) expressed by a 
neuron, which loosely suggests a neuron’s function in the neural circuitry 34. Attempts to classify 
specifically GABAergic interneurons have also been based on their different firing patterns 35 
and their expression of certain molecular markers; almost all GABAergic interneurons will 
express one of the following three markers: parvalbumin, which is a calcium-binding protein, 
somatostatin, a peptide hormone which acts as a neurotransmitter, and 5HT3aR, which is a 
serotonin receptor 36.  
 
More recently, with the development of RNA sequencing (RNAseq) technologies, new 
classification efforts have been focused on characterizing the expression of genes that are 
differentially expressed in closely-related cells that have different physiological properties. 
Through dimensionality reduction analysis, large data sets with potentially related variables can 
be simplified while still retaining the most significant components; these reduced data sets can 
then be graphed to visualize how closely aligned different samples or groups are, based on how 
similar their components are 37. Multiple attempts at creating inhibitory interneuron 
subpopulations based on RNAseq have been performed, with little consensus. One such study 
claims to establish distinct “cardinal types” of GABAergic interneurons, based on the expression 
of one of the following molecular markers: parvalbumin, somatostatin, the peptide hormone Vip, 
the inhibitor of DNA binding gene Id2, the gene that converts tyrosine to dopamine Th, a nitric 
oxide synthase Nos1, and a binding protein for insulin-like growth factors Igfbp6 38. Each of 
these cardinal types also had associated genes that are more transcribed in that subpopulation; 
markers for somatostatin-containing interneurons included a cell membrane glycoprotein 
Tspan7 and a binding protein for AT-rich sequences Satb1, whereas markers for parvalbumin-
containing interneurons included myocyte enhancer factor Mef2c, a receptor tyrosine-kinase 
Erbb4, and the phospholipase Plcxd3 38. Another study using dimension reduction suggests 
that, even before the actual genes somatostatin or parvalbumin are expressed, there are distinct 
somatostatin and parvalbumin clusters of embryonic neurons by E14.5 39. This study also 
suggest the cyclin Ccnd2 and zinc-finger transcription factor St18 are early markers of 
parvalbumin-expressing GABAergic interneurons, whereas the ephedrine receptor Epha5 is a 
marker for the somatostatin-expressing variety 39. Although these genes were identified through 
single cell RNAseq, there have not been attempts at in situ hybridization, 
immunohistochemistry, or any other experiments to verify these transcripts are being produced 
or being translated into proteins yet.  
 
Because NG2 cells can react to injuries in vivo, are derived from the same progenitor cell as 
GABAergic interneurons, and interact with and respond to neurotransmitters, these cells are 
viable candidates for in vivo reprogramming into neurons after an injury. After a central nervous 
system injury, introducing either the transcription factor Sox2 alone or both Sox2 and Ascl1 
through retroviral vectors was seen to induce NG2 glia to differentiate into neurons expressing 
doublecortin, a microtubule-associated protein and a marker for immature neurons, in vivo 40. 
When a retroviral vector containing the transcription factor NeuroD1 is introduced post-injury, 
the NG2 cells are reprogrammed into a mix glutamatergic (excitatory) and GABAergic 
(inhibitory) neurons 41. With vectors containing Ascl1, Lim homeobox transcription factor Lmx1a, 
and transcriptionally-inducible nuclear receptor Nurr1 (ALN vectors), more than half of the NG2 
glia in the surrounding area are reprogrammed, and the majority of these have the 
electrophysiological properties of fast-spiking, parvalbumin-containing GABAergic interneurons 
42. 
 
Although multiple constructs have been used for transfecting these cells into neurons, using 
Dlx-2 has been less explored, although its regulatory role in differentiating NPCs suggest this 
should be a viable construct. Preliminary work done by other members in the Nishiyama lab had 
looked at trying to induce NPC differentiation into astrocytes, and an RNAseq search looking at 
differentially expressed transcription factors between NPCs, NG2 cells and astrocytes included 
Dlx-2. Linda Boshans transfected NG2 cells with a Dlx-2 containing vector (pCMV-Dlx2-IRES2-
mCherry) and found that, by 14 days post-transfection (DPT), the transfected NG2 cells had 
different responses to electrical stimulation in patch-clamp recording experiments than NG2 
cells do and they expressed GABA. The majority of these cultures showed immature neuronal 
characteristics, which include unstable resting potentials, high membrane input resistances, and 
an inability to produce action potentials 43; some cultures have fast-spiking characteristics, 
which are commonly seen in parvalbumin-containing neurons because of their expression of the 
voltage-gated potassium channels in the KV3 family 44.  
 
Based on these early results, we became interested in the expression of the recently published 
marker genes for proposed GABAergic interneuron subtypes, hoping to characterize our 
transfected NG2 cells as mainly expressing markers from either a distinct subtype or multiple 
subtypes; because some of the early electrophysiological results included fast-spiking neurons, 
the early hypothesis was that early parvalbumin marker genes would be some of the most 
differentially expressed. 
 
To investigate the expression of these characteristic genes, a project focused on quantitative 
reverse-transcriptase polymerase chain reactions (qRT-PCR) was designed. Using this, the 
transcription of selected genes of interest can be quantified and compared between different 
samples, suggesting which proteins are being more expressed. Our transfected NG2 cells are 
cultured with astrocytes to maintain a healthy cell culture, and we want to ensure that the 
transfection protocol itself is not driving any changes in expression; to account for these, nearly 
identical plasmids were created (both were mCherry-containing plasmids, with the only 
difference being one contained Dlx-2) and transfected into identical cultures. Genes of interest 
were mainly selected from the two recent papers trying to classify different subpopulations of 
GABAergic interneurons 38,39, along with three control genes: the OPC cell marker NG2 (which 
was expected to decrease in expression), the astrocyte marker glial fibrillary acidic protein 
GFAP, and glutamate decarboxylase 1 (Gad67, the enzyme that produces GABA, which was 
expected to increase in expression). All samples were collected at 14DPT, to mirror the time 
point at which the preliminary electrophysiological recordings had taken place. 
  
Materials and Methods 
Animals 
 
 For all experiments, CD1 mice from Charles River Laboratory (strain #022) were used, 
and all experiments were approved by the Institutional Animal Care and Use Committee 
(IACUC).  
 
Cell Culturing (all done by Linda Boshans) 
 
Plasmid Preparation 
 The entire transcript of mouse Dlx2 cDNA (NM_010054.2, from translation start site to 
the stop codon) was inserted into a pCMV-IRES2-mCherry vector (obtained from Dr. Hitoshi 
Gotoh, Kyoto Prefectural Medical University), originally created by adding the mCherry coding 
sequence in place of the EGFP coding region in a pIRES2-EGFP vector (Clontech). 
 
Purifying, Culturing and Transfecting NG2 Cells 
NG2 cells were isolated from the postnatal day 2-3 (P2-3) CD1 mice acquired from the 
Charles River Laboratory through an adapted version of an established sequential 
immunopanning purification procedure 45. Isolated cortices were cut and incubated in a papain 
solution (20U/ml; Worthington) at 35oC for an hour. Next, these cortices were ground, 
surrounded by a BSA and ovomucoid solution, and this mixture was passed through a 70-um 
cell strainer. The ensuing cell suspension was incubated on a petri dish with the O1 antibody 
(Gift from Dr. Steven Pfeiffer at University of Connecticut Health Center, 1:1 dilution) 46 on its 
surface to extract the mature oligodendrocytes from the mixture. The remaining supernatant 
was incubated on another petri dish, which was covered in rat anti-mouse platelet-derived 
growth factor receptor alpha (PDGFRα) antibody (CD140a, BD Biosciences, 2μg/ml) to isolate 
the NG2 cells expressing this receptor. The remaining solution was washed away with 
phosphate-buffered saline (PBS), and the remaining bound NG2 cells were isolated and 
collected via trypsinization.  
These cells were then centrifuged at 1100 rpm for 5 minutes and resuspended in a 
mixture of platelet-derived growth factor (PDGF) and Dulbecco’s Modified Eagle Media 
containing Sato’s supplements (DMEM-Sato’s,Peprotech). These cells were then either plated 
onto glass coverslips (Fisher) with either 100ug/ml of poly-D-lysine (Sigma-Aldrich) and 15 ug 
laminin (Sigma-Aldrich) or with 30ug/mL of poly-L-lysine (PLL, Sigma-Aldrich) or onto tissue 
culture dishes (Fischer) also coated with that same concentration of PLL.  
16 hours after being plated with the PLL or PDL and laminin, the NG2 cells were 
transfected with either the pCMV-Dlx2-IRES2-mCherry (Dlx-2) plasmid DNA or the control 
pCMV-IRES2-mCherry (mCherry) plasmid DNA, using the Lipofectamine 2000 (Invitrogen). Five 
hours after transfection, the DMEM-Sato’s solution with 50ug/mL PDGF-AA (Peprotech) was 
fully replaced.  
 
Three days post-transfection (DPT), these cells were trypsinized to free them from these 
plates or coverslips. The freed cells were then plated on an astrocyte-coated glass coverslip 
(125,000 astrocytes per 12mm surface area), and a neuronal differentiation media (comprised 
of 1% N2 supplement [Gibco], 1% B27 [Life Technologies], 1% L-glutamine and 1% Pen-Strep 
in DMEM/F12 containing 50ng/mL human brain-derived neurotrophic factor [BDNF, Peptrotech]) 
was applied. This media is again switched at 7DPT to a neuronal maturation media (Neurobasal 
A supplemented with 2% B27, Glutamax, 1% Pen-Strep and 50 ng/mL human BDNF). Half of 
the cell culture’s media was replaced every three days, and at 10DPT, 1% horse serum was 
also added to supplement the astrocytes.  
 
Astrocyte Culturing 
During the time when NG2 cells were purified, cortical astrocytes were isolated 
according to previously published protocols 47,48, resuspended in astrocyte media, and placed in 
a T75 culture flask with the aforementioned 30ug/mL PLL solution, which was changed every 2-
3 days. Between days 7 and 9, the astrocyte layer on these flasks covered the entire bottom of 
the flask, and at this time the flasks were shaken at 260 rpm overnight to free the astrocyte layer 
from any other cell types. The following day, the free-floating remnants were washed away with 
PBS. The remaining adhered astrocytes were freed via trypsinization and frozen in aliquots for 
later plating onto glass coverslips.  
 
qRT-PCR Primer Design 
 
Based on previous GABAergic interneuron subtype analyses, fourteen genes of interest were 
chosen to be quantified, not including the housekeeping gene Rn7sk. Three of the genes of 
interest and the housekeeping gene had previously been designed and optimized by 
researchers in the Nishiyama laboratory. The remaining eleven genes’ transcripts were 
identified on Ensembl 49 and sequences containing exon-exon junctions were selected and used 
in the NCBI Primer-BLAST tool 50 for primer design. Primers were selected that would produce 
products between 100 and 200 base pairs long and had low self-complementarity and self 3’ 
complementarity. For the primer sequences, see Table 1. 
 
Table 1 
Gene Forward Primer (bp/Tm in oC) Reverse Primer (bp/Tm) 
Sst  CCCCAGACTCCGTCAGTTTC (20/60) GGCTCCAGGGCATCATTCTC (20/61) 
Pvalb GGCCTGAAGAAAAAGAACCCG (21/60) ATCTTGCCGTCCCCATCCTT (20/61) 
Satb1 GTGCGGGATGAACTGAAACG (20/60) GGCTTCCGGCAACTGTAAGA (20/60) 
Mef2c CACGAGAGCCGGACAAACT (19/60) AGGTGGAACAGCACACAATCT (21/60) 
Ccnd2  TACCTGGACCGTTTCTTGGC (20/60) CCCAACACTACCAGTTCCCA (20/59) 
St18 CAGGGCAAGGACAAAAAGCAC (21/61) AGCGGGTGGAAAGGTTCAG (19/60) 
GFAP* TGAATCGCTGGAGGAGGAGA (20) CGTATTGAGTGCGAATCTCTCTCA (24) 
Gad67*  ACAGAGACCGACTTCTCCAAC (21) GAGCGATCAAATGTCTTGCGG (21) 
NG2* CTTCTTCGGGGAGAACCACC (20) CTTCTGTCCCAGGGCAAGTC (20) 
Epha5 TGGAGAGAGACCCTACTGGGA (21/61) TGATAGAGAGCAGCAGGGCA (20/61) 
Vip TAGCAGAAAATGGCACACCCTA (22/60) TGTCGTTTGATTGGCACAGG (20/59) 
Erbb4 GCTGCTGTTGAACTGGTGTG (20/60) TCACTAAGACATTGCGGGCT (20/59) 
Plcxd3 GCAAACACGACAGACCCAGA (20/61) TGCATCATGGCGGGAAGAG (19/60) 
Id2 GCATCCCACTATCGTCAGCC (20/61) ATTCGACATAAGCTCAGAAGGGA (23/59) 
Rn7sk* CTCCAAACAAGCTCTCAAGGTCCA (24) ATGCAGCGCCTCATTTGGATGTGT (24) 
 Starred genes had been previously designed and optimized by the Nishiyama laboratory 
 
RNA extraction protocol 
 
To prepare the CD1 cortical samples for RNA extraction, the samples first had to be isolated 
and pulverized. After euthanizing the mouse with carbon dioxide followed by cervical 
dislocation, Linda removed the brain from the skull, and isolated the cortex from the cerebellum. 
She then cut the cortex into 100mg parts, flash-froze the samples with liquid nitrogen, and 
stored them at -80oC. At a later time, I chilled a spatula, mortar and pestle using liquid nitrogen, 
submerged the piece of cortex in the liquid nitrogen in the mortar, and ground the sample into a 
fine powder. The sample was then transferred into an Eppendorf tube using the chilled spatula 
for future steps. 
  
For both the cultured cell samples and the triturated CD1 mouse brain samples, PureLink RNA 
Mini Kit extraction protocol with DNase was followed according to manufacturer’s guidelines 51. 
At this point, total RNA had been isolated from the samples and a spectrophotometer was used 
to test the concentration of the RNA. Finally, 5ug aliquots were made, along with adding 1/10 
the volume of TE pH 7.0 to increase stability, and stored at -80oC. To ensure the quality of the 
samples, all RNA samples used to create cDNA libraries were tested on an Agilent 2200 Tape 
Station at the Center for Genome Innovation at the University of Connecticut, with the guidance 
of Bo Reese, who was in charge of sequencing. 
 
  
cDNA synthesis  
 
 The extracted RNA samples underwent cDNA synthesis reactions using the SuperScript 
IV First-Strand Synthesis System (InVitrogen) according to a modified version of their protocol 
52. Put briefly, between one and two micrograms of RNA was diluted in 10 uL of RNase-free 
water, 20uM of random hexamers (as opposed to 50uM recommended), and dNTPs to incubate 
at room temperature. Next, 20uM Oligo(dt)20 was added (as opposed to the 50uM 
recommended), and the mixture was incubated at 65oC and rapidly placed on ice. Next, a mix of 
5x Superscript IV buffer,  DTT, RNaseOUT, water and 10 units of Superscript IV (as opposed to 
20 units recommended) was added to the RNA mixture and incubated at 50oC for 15 minutes, 
immediately followed by incubation at 80oC to inactivate the reverse transcriptase, and then 
placed on ice. Finally, RNase H (New England Biolabs) was added and the tubes were 
incubated at 37oC to degrade the original RNA. These samples were then diluted to the desired 
concentration, aliquoted, and stored at -80oC for future use. 
 
Quantifying samples with qPCR 
 
The cDNA produced from a cDNA synthesis reaction with 20 ng of RNA was used for each 
reaction, mixed with SsoAdvanced Universal SYBR Green Supermix (Bio-Rad, Hercules, CA) 
as recommended by the manufacturer’s protocol for 20uL reactions 53. The amount of primers 
added to any given gene’s reactions was based on primer optimization experiments (described 
later in this thesis). Samples were run in duplicate on the Bio-Rad CFX96 (Bio-Rad, Hercules, 
CA) with the 2 step Amp+Melt protocol. In the amplification portion of the protocol, the first three 
minutes are at 95oC to activate the transcriptase and denature any double stranded cDNA, 
followed 40 cycles of ten seconds at 95oC for denaturation, thirty seconds at 55oC for annealing 
and elongation, and finally a fluorescence measurement to end each cycle to quantify the 
amount of double stranded DNA product in each well. This is followed by the melting portion of 
the protocol, which consists of 30 cycles of five seconds at 65oC to allow products to anneal, 
followed by stepwise 0.5oC increases each second up to 95oC, constantly measuring 
fluorescence to measure when the products separate. The 2−ΔΔCT method was used to 
determine relative fold changes between samples, with Rn7sk serving as the housekeeping 
gene for all comparisons.  
 
  
Results 
 
Primer Optimization 
 
To make sure that all of the genes of interest are adequately expressed in the cDNA library 
used for primer optimization, mouse P21 cortical tissue was chosen. The expression of Vip, Sst, 
and Gad21 all are at a maximum by P21, and although PV’s expression does not truly peak until 
P35, there is relatively little change between P21 and P35 54. Because of these findings, RNA 
was isolated from the cortices three different P21 mice, producing five different samples (one 
from the first mouse and two each from the other two).  
 
To compare the quality of these different RNA samples and determine which is worth using for 
the primer optimization, a Agilent’s Bioanalyzer 2200 Tape Station’s High Sensitivity RNA assay 
was used. This assay uses Agilent’s novel RNA Integrity Number (RIN) as a measure for the 
degradation and quality of an RNA sample, ranging from scores of 1 (completely degraded 
RNA) to a 10 (intact RNA). This algorithm works with total eukaryotic RNA, taking into account 
the ratio of the ribosomal 18S and 28S bands and the levels of smaller fragment RNAs 
compared to those ribosomal bands 55. Although the initial quality of the RNA can have 
significant effects on the Ct values for a sample and can slightly affect primer efficiencies; 
because of this, RIN values above 7.5 (corresponding to minimal degradation and mostly intact 
RNA) are ideal for any type of qPCR or RNA quantification procedures 56. The RINs for these 
five samples ranged from 7.7 to 8.2, with the cortical RNA sample with a RIN of 8.2 being 
chosen for future cDNA synthesis reactions for qPCR primer optimization (data not shown). 
 
Because a single qPCR plate was used for the optimization and testing of multiple primer pairs, 
all primers designed here needed similar annealing temperatures. Annealing temperatures are 
the temperature where the maximum amount of primer is bound to its template, but can vary 
based on whatever buffers or inhibitors are in the master mix; because of this, a primer’s 
melting temperature is typically predicted by primer design algorithms as a conduit 57. The 
melting temperature is the temperature where half of the primers in a solution would be bound 
to their perfect complement (the template cDNA), so PCR annealing temperatures are typically 
4-6 degrees Celsius below the melting temperature of primers. The melting temperature can 
typically be predicted based on the percentage of guanine and cytosine in the sequence (since 
these will have 3 hydrogen bonds, compared to the 2 hydrogen bonds between adenine and 
thymine) and the length of the oligonucleotide primers 58. Because the qPCR protocol used 
called for an annealing and elongation step temperature of 55oC, primers were designed to 
have melting temperatures between 59oC and 61oC, which were attained by keeping GC 
concentrations between 40% and 60% of the bases in each primer and keeping all primer 
lengths between 19 and 23 base pairs. 
 
For these designed qPCR primers to meet our lab’s standards for quantification, the efficiency 
of the primers had to be within 5% of 100% efficiency and only amplify a single product. A 
reaction having 100% efficiency implies that the polymerase enzyme is working at its maximum 
capacity (having the same rate of reaction) across each of the different serial dilutions of the 
cDNA library produced by the cDNA synthesis reaction, and can be calculated by the equation  
E = -1+10(-1/slope), where the slope refers to the standard curve where the Ct is on the y-axis and 
the log of the DNA concentration added is on the x-axis 59. Because the polymerase enzyme 
working at maximum efficiency will double the amount of the amplicon each cycle, the ΔCt 
values for each of the five-fold serial dilution is 2.32. During that serial dilution, both the cDNA 
and any DNA Polymerase inhibitors are being diluted; having less inhibitors in the higher-order 
serial dilutions than the higher concentration samples can skew the ΔCt values, making them 
less than this ideal 2.32 and giving an efficiency of over 100%. In higher order dilutions, 
stochastic effects of how the transcripts are distributed within the volume pipette compared to 
the rest of the sample can play a larger role as the overall number of transcripts decreases; this 
means that there can be more variability in Ct values and the ΔCt the more diluted the cDNA 
samples get 60. Avoiding changes or introducing any potential inhibitors is a reason why it is 
important to follow the same RNA isolation protocol exactly when isolating both the RNA for 
optimization and for the experimental results. Making sure that only the desired section of the 
gene of interest is being amplified, and no off-target products, is key because the fluorophore in 
SYBR Green only measures the amount of double-stranded DNA, and not what that DNA 
segment is. For similar reasons that primers can have different melting temperatures, so can the 
amplicons; any off-target products produced will most likely have different lengths and different 
amounts of G-C and A-T bonds, both giving them different melting temperatures and making 
them separable in a gel electrophoresis; this provided two ways to detect primer non-specificity.   
  
After primer pairs were designed and ordered, multiple genes were optimized on the same 
qPCR plate. Although the actual amplification curves all overlap (figure 1A), there are distinct 
melting curve profiles with their own temperature at which maximum dissociation occurred 
(figure 1B). Looking specifically Id2’s amplification, the number of cycles needed for each of the 
samples in the five-fold serial dilutions to reach threshold was close to the ideal 2.32, but 
increased slightly as the cDNA was more diluted (figure 1C); as expected, all of the Id2 
samples’ melt curves have a single peak that align with one another(figure 1D). 
  
For many of the designed primer pairs, the initial primer concentration tested would amplify a 
single product, but would give an efficiency just outside of that acceptable 95%-105% range 
(typically within 5-10% of that range). Primers were first tested at a final concentration of 300uM 
for each of the forward and reverse primer in the qPCR reaction mix, but if this did not give an 
appropriate reaction efficiency, then primer concentrations of 150uM and 450 uM were both 
tried as well. All primers used in this study worked at one of these three concentrations.   
  
For the primer pairs targeting Plcxd3 and Erbb4, multiple peaks or more broad curves were 
generated in their melt curves (figure 2A for Plcxd3), which does not necessarily mean multiple 
products were generated, but can be an indicator of this. To verify that these primers produced 
off-target amplicons, the reaction’s products were run on a 2% agarose gel alongside a 1Kb 
Plus DNA Ladder. Multiple bands or smearing in the same well on this gel indicated products of 
multiple lengths, and therefore multiple products, had been generated (figure 2C for Plcxd3). 
Another pair of primers for each of these genes was be designed, ordered, and tested; the 
second primer pairs for each of these genes met the optimization standards (figure 2B and 2D 
for Plcxd3). 
 
 
 
 
Figure 1: Successful Primer Optimization and Melt Curves 
Figure 1. (A) The amplification curves for four different primers show nearly all samples having Ct values 
between 20 and 30, with the negative control, lacking cDNA, never approaching threshold during the forty 
cycles. (B). Melt peaks for four different primer sets each have distinct and narrow peaks (from left to 
right, Rn7sk, Parvalbumin, Somatostatin and NG2), showing specificity of product. These peaks 
correspond to the temperature at which there was the greatest change in fluorescence, which for SYBR 
green, indicates when the products went from being double-stranded DNA to single-stranded DNA. (C) 
The amplification curves for Id2’s optimization shows roughly equidistant gaps between the five 
concentrations of cDNA used [efficiency for these primers were 95.53]. (D) The melt curve and melt 
peaks for Id2’s optimization show each qPCR reaction using the Id2 primers, at the five different cDNA 
concentrations, all shared the same peak melting temperature and have narrow peaks.  
 
Figure 2: Melt Peaks and Non-Specific Products 
Figure 2. The first primer pair designed for the gene Plcxd3 generated a products with multiple melt 
peaks, implying non-specificity (A). The second primer pair designed for Plcxd3 has a much more 
consistent peak at approximately 84oC, the same temperature as the largest peak seen when using the 
previous Plcxd3 primer pair, and less variability outside of the peak (B). When these products were run on 
2% agarose gel, The first primer pair’s products showed smearing and multiple bands, whereas the 
second primer pair had one distinct band (C and D). 
 
Transfected NG2 Cell Results 
 
Five replicates of astrocytes, mCherry-transfected NG2 cells, and Dlx2-transfected NG2 cells 
were cultured and had their RNA extracted. The cDNA generated from each sample in these 
replicates were used for qPCR, with all samples for the same gene tested on the same qPCR 
plate at the same time to ensure consistency; all plates were run using the reference gene 
Rn7sk. For all mCherry-transfected and Dlx2-transfected samples, the housekeeping gene 
Rn7sk always was within one cycle in terms of reaching threshold for each replicate.  
 
Between the five replicates’ qPCR data, the second replicates’ comparative Ct (ΔΔCt) values 
were significantly different across almost every gene. When analyzing the difference in Ct 
values between each gene of interest and the housekeeping gene for both the experimental 
Dlx2-transfected samples and the control mCherry-transfected samples (ΔCtE and ΔCtC, 
respectively), there were no noticeable outliers compared to the rest of the replicates. However, 
the difference between the ΔCtE and ΔCtC (ΔΔCt) does stand out for these samples: in 
replicate #2, every gene except Gad67 and Vip appears to have reduced expression in the 
Dlx2-transfected sample, whereas in the average of the other 4 replicates, every gene except 
for Id2 appears to be transcribed at higher levels in the Dlx2-transfected samples (data not 
shown). Because the supermajority of genes have the opposite expression fold changes in this 
one replicate, it has been excluded from all future analysis. 
 
The relative expression fold changes of the four analyzed replicates show that marker genes 
from multiple subtypes are differentially expressed in the Dlx2-transfected samples (Figure 3). 
Gad67 is significantly more transcribed in these samples, indicating that the transfected NG2 
cells are more able to produce GABA and are likely transforming into inhibitory neurons. 
Although not statistically significantly altered because of relatively large standard deviation, Id2’s 
average expression rate has decreased in this sample, indicating these newly-forming 
GABAergic interneurons are probably not belonging to this cardinal subtype. However, one 
marker gene for each of somatostatin- and parvalbumin-subtype (Satb1 and Erbb4, 
respectively) interneurons, along with somatostatin itself, are significantly more transcribed in 
the Dlx2-transfected population; the cardinal subtype gene Vip also has increased expression in 
all four replicates, hinting at a mixed phenotype. 
 
 
Figure 3: qPCR Expression Changes in Transfected NG2 Samples 
Figure 3. The relative expression fold changes of the genes of interest between the NG2 cells transfected 
with the Dlx2-vector and the mCherry-vector. Many of the marker genes for somatostatin- and 
parvalbumin-expressing GABAergic interneurons are more transcribed in the Dlx2-transfected cells. 
Somatostatin, its marker gene Satb1, the Parvalbumin marker gene Erbb4, and the GABA-producing 
Gad67 gene are all significantly differentially expressed (p<0.05) according to a student’s t-test for these 
samples.  
 
Because each of these replicates was cultured and stored at separate times before RNA 
extraction, and each sample’s RNA extraction was run in parallel, there could have been 
differences in the quality of RNA derived from each sample. All samples from replicates one 
through four had at least a RIN of 7.9, with almost all samples with RIN values in the 8s (data 
not shown). However, replicate 5 had significantly worse RIN values, with the Dlx2-transfected 
sample having a RIN of 7.1, and the mCherry-transfected sample having a RIN of 6.8 (data not 
shown). Because these values are below the general standards for intact RNA, replicate 5’s 
qPCR data can also be reasonably excluded from future analysis. 
 
Excluding replicate five from relative expression analysis shows that most genes of interest 
appear to be similarly expressed in the remaining samples, but moving from n=4 to n=3 can 
negatively affect the statistical significance (Figure 4). There are two genes (somatostatin 
marker Satb1 and early parvalbumin marker Ccnd2) in which replicate 5 had been an outlier, 
and removing replicate five increased the statistical significance of their expression fold change 
to below (p<0.01) by greatly decreasing the standard deviations. The actual replicate 5 
comparative Ct for Erbb4 lined up with the other replicates, and losing that sample increased 
the standard deviation enough to no longer make that gene’s change in expression statistically 
significant. In spite of removing replicate 5, the data still suggests a mixed GABAergic 
phenotype for these Dlx2-transfected cells. 
  
  
 
Figure 4: qPCR Expression Changes Comparison when Excluding Low-Quality Samples 
Figure 4 After excluding replicate 5 due to poor RIN values for its RNA, there changes in 
average expression fold change are relatively minor. A student’s t-test (* indicates p<0.05, ** 
indicates p<0.01) shows that statistical significance was lost for the parvalbumin marker gen 
Erbb4 by removing replicate 5, but early parvalbumin marker gene Ccnd2 and somatostatin 
marker Satb1 both gained in statistical significance.  
 
The raw Ct values for this data also gives an idea of how expressed these genes of interest are 
in our samples. Because primers with efficiencies of 100 ± 5% were chosen, the amount of 
transcript should double in each qPCR cycle. Genes that are more expressed need less cycles 
to reach their Ct value. Ct values are most reliable within their linear dynamic range of 20 and 
30 61, and Ct values above 35 will have more variability, making them less reliable for analysis 
62. All of the average Ct values fell between 20 and 35 with the exception of GFAP, which is only 
highly expressed in the astrocytes these NG2 cells were plated onto. 
 
The Ct values for the Dlx2-transfected samples put into perspective the significant increase in 
transcription of certain genes. Somatostatin’s Ct value average among samples is 34, whereas 
parvalbumin’s average Ct value is 23. This means that, although the transcription of 
somatostatin was significantly increased in the Dlx2-transfected sample, there was still 
approximately a 2000-fold expression difference between somatostatin and parvalbumin, 
suggesting parvalbumin may be influencing the phenotype of these GABAergic interneurons 
more than previous analysis suggested. Along similar lines, although Vip is transcribed at higher 
levels in the Dlx-transfected samples in figures 3 and 4, its average Ct value is only 31, leaving 
it 250 times less expressed than parvalbumin in these samples (although more expressed than 
somatostatin). For reference, the somatostatin marker genes and all of the parvalbumin marker 
genes except Plcxd3 have average Ct values between 21 and 26, suggesting somatostatin’s 
expression could continue to increase to approach these Ct values if a later time point were 
tested (data not shown).  
 
 
  
Discussion 
Although the advent of RNA sequencing has given much more information on which genes are 
expressed in specific cells, how to best use this data is still unclear. Past classifications of 
neurons have all been based on easily observable or more clearly defined characteristics (their 
electrophysiology, morphology, which neurotransmitters and receptors they express, etc., 
(DeFelipe 2013)); it is not as easy to determine how a particular gene being more or less 
expressed can affect a cell’s functions, especially when many genes’ expressions are 
correlated, like the genes listed as markers for Mi’s and Mayer’s cardinal types of neurons. 
There is currently no standard for what level of difference would be needed in the gene 
expression between groups of cells to classify them as different groups, or if these different 
groups would even have different functions within the central nervous system.  
 
Dimensionality reduction techniques have provided a statistical way to try and cope with these 
issues with large data sets, but still have their own issues. Feature selection approaches, where 
discrete pieces of data (for example, the expression of one intentionally selected gene) are 
compared directly, can be too difficult to parse or find meaning in when tens, hundreds or 
thousands of features could be selected; dimensionality reduction tries to approach this problem 
by finding which components (or eigenvectors) are the most significant (or has the highest 
eigenvalue) when finding differences between groups, and can transform this data graphically to 
highlight differences. Some techniques, like linear discriminant analysis (LDA) and t-distributed 
stochastic neighbor embedding (t-SNE), are considered “supervised” and are meant to 
maximize differences between groups when samples have already been arbitrarily put into 
groups; unsupervised techniques like principal component analysis  (PCA, which is used in both 
the Meyer et al. 2018 and Mi et al. 2018 studies) are meant to maximize variance between each 
sample, and any type of grouping can be done after the fact 63. Some methods, like PCA, rely 
on linear algebra and will produce the same result every time they are performed on the same 
data set; other methods, like t-SNE and LDA, can provide “less stable” results, giving slightly 
different results in different iterations performed with the same data 64. Because of these 
differences, it is understandable why these preliminary studies are using PCA; once there is 
more consensus on what groups or subgroups of GABAergic interneurons exist, techniques like 
LDA may be more informative. 
 
The optimization process for these qPCR primers relied upon two different parameters: 
amplifying a single product, and operating within 5% of 100% primer efficiency. During primer 
design with Primer-BLAST, primers were already run through a computer algorithm to look for 
potential off-target products that could be amplified in the mouse genome, but it is still important 
to verify that only a single product is being generated by the primers. Because the melting point 
of any amplicon depends on both the length of the amplicon and the actual sequence’s amounts 
of C-G and A-T bonds, melting points of amplicons are an easy way to screen for multiple, 
different amplicons being produced. Having a narrow, sharp melting curve peak indicates that 
all of these amplicons are dissociating with their complementary strand at the same 
temperature; because that dissociation depends on the composition of the bonds and how many 
there are, this is a reasonable conduit for looking at product specificity. When multiple peaks 
were seen in two of the primer pairs tested, this suggested that either amplicons of different 
lengths or amplicons with different nucleotide compositions had been generated, and the gel 
electrophoresis confirmed both times that products of different lengths had been amplified. This 
was a clear sign that the primer pairs in question were not amplifying a single, specific product, 
and prompted the ordering of new primer pairs. Because the effects of primer and reaction 
inefficiency are compounded each cycle, it was imperative that these reactions are optimized 
before being used in experiments, or else Ct values could vary significantly. The ΔΔCt method 
relies upon the quantification of the cDNA of a particular gene in two different groups of samples 
(here, iterations of both the Dlx-2-transfected samples and the mCherry-transfected samples), 
so if any of those samples differ in the starting amount of of cDNA of that particular gene, the 
unoptimized reaction’s compounding error would skew the results and any comparisons made 
between samples. 
 
Although parvalbumin is much more expressed in these transfected samples than somatostatin 
is, the parvalbumin expression is also quite high and variable in even the astrocyte-only 
samples from the replicates, with a Ct range between 23 and 29 (data not shown). There is a 
chance the way the cell culture itself was designed is leading to high parvalbumin expression, 
and not the NG2 cells being transfected; the lack of statistical significance in the change of 
expression of parvalbumin in the analysis would support this. Finding a way to prepare and 
transfect the NG2 cells using less or no astrocytes could reduce this level of background noise 
and make better comparisons of parvalbumin and somatostatin expression levels in the qPCR 
samples possible.  
 
Our research confirms that transfecting NG2 cells with a Dlx2-vector increases the expression 
of some genes required for becoming inhibitory GABAergic interneurons by 14DPT, including 
the GABA-producing Gad67 and various somatostatin and parvalbumin marker genes. The 
variety of classes of marker genes having increased expression, and the lack of all genes in any 
given category being differentially expressed) suggests a mixed phenotype, but further 
electrophysiological testing or gene expression analysis at a time point later than 14DPT could 
strengthen this characterization, since different GABAergic interneuron types have different 
characteristic responses 42. Confirming the expression of key genes, like Gad67, parvalbumin, 
somatostatin and Vip through in situ hybridization can also be useful in classifying this type.  
 
Although we have shown increases in key GABAergic interneuron genes by 14DPT, future 
experiments looking at 2DPT and 7DPT could shed further light onto which genes’ transcription 
levels are first affected, and could potentially lead to finding the mechanism of how increasing 
Dlx2 can cause this transformation in NG2 cells. Increasing the number of replicates tested 
could also help reduce the standard deviations and better elucidate which genes’ expressions 
are significantly affected, rather than just being affected as an outlier in one or two replicates 
enough to skew the data.  
Conclusion 
Recent studies have shown NG2 cells can be transformed to follow a neuronal fate, and which 
of the constructs were used affect what types of neurons are produced. Recent attempts on how 
to classify different types of GABAergic interneurons lacks consensus, so for this study, genes 
of interest were identified from multiple studies. Overall, fourteen novel primer pairs for qRT-
PCR were used and optimized for providing insight into what types of neurons are produced by 
our Dlx-2-transfected NG2 cells. Electrophysiological testing at 14DPT mainly showed an 
immature GABAergic neuronal phenotype for these cells, with a minority behaving more like 
fast-spiking parvalbumin-containing GABAergic interneurons. The qRT-PCR results from 14DPT 
samples also show that the GABA-producing Gad67 is significantly more expressed, alongside 
a few parvalbumin- and somatostatin-subtype associated genes, but most genes are not 
significantly changed in their expression, suggesting a mixed phenotype for these Dlx-2-
transfected cells, at least at this time point. 
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